DR. JOSÉ SIFUENTES OSORNIO


Education:

  • 1985 – Post-doctorate in Clinical Microbiology, University of Virginia.
  • 1983 – Specialty in Infectology, INNSZ.
  • 1981 – Specialty in Internal Medicine, INNSZ.
  • 1976 – Surgeon, Autonomous University of San Luis Potosí.

Academic appointments:

  • Head of the Laboratory of Clinical Microbiology and Professor of Medicine at the Salvador Zubirán National Institute of Medical Sciences and Nutrition.
  • Professor of Medicine and Infectology at UNAM since 1986 and tutor of the Biomedical Sciences and Medical Sciences programs at UNAM since 1989.
  • Full member of the National Academy of Medicine (1999), Fellow of the American Academy of Microbiology (2000); member of the Councils of Internal Medicine (1997-2005) and of Infectology (1994-1998). Member of the Advisory Committee of the National Program for the Control of Tuberculosis (since 2001).
  • Member of the committees to review and evaluate research projects or awards or recognitions in: CONACYT, National Institutes of Health of the United States (NIH), Wellcome Trust, Mexican Foundation for Health, Chilean Council of Sciences and Technology, Glaxo-SmithKline Foundation, and Pfizer Foundation.
  • Researcher affiliated with CISIDAT.

Research interests:

  • Tuberculosis and antimicrobial resistance.

Featured projects:

  • Founder of the Mexican Network for the Study of Bacterial Resistance, the Mexican Consortium for the Study of TB, and the Mexican Candidemia Network. Principal Investigator and Founder of the National Clinical Laboratory for Maximum Biological Safety for the study of tuberculosis and emerging diseases located at INCMNSZ.
  • He has been distinguished with 38 national and international awards for his research work, including: National Institute of Health Award (6 times), National Research Award by the Glaxo Foundation (4 times), Association Award Mexican of Infectology and Clinical Microbiology (15 occasions), FUNSALUD 2003 Biennial Award in Ophthalmology, CIBA-GEIGY Award in Clinical Research in Rheumatology, among others. He conducts basic, clinical, and epidemiological research in the fields of tuberculosis and antimicrobial resistance with funding from the NIH, Wellcome Trust.

SELECTED PUBLICATIONS

  • Simvastatin Enhances the Immune Response Against Mycobacterium tuberculosis. Guerra-De-Blas PDC, Bobadilla-Del-Valle M, Sada-Ovalle I, Estrada-García I, Torres-González P, López-Saavedra A, Guzmán-Beltrán S, Ponce-de-León A, Sifuentes-Osornio J. Front Microbiol. 2019 Sep 20;10:2097.
  • Azole resistance and cyp51A mutation screening in Aspergillus fumigatus in Mexico. Gonzalez-Lara MF, Roman-Montes CM, Diaz-Lomeli P, Rangel-Cordero A, Valenzuela MO, Ponce-de-Leon A, Sifuentes-Osornio J, Ostrosky-Zeichner L, Martinez-Gamboa A. J Antimicrob Chemother. 2019 Jul 1;74(7):2047-2050.
  • Enfermedad granulomatosa hepática. Ortiz-Brizuela E, Azamar-Llamas D, Mora JD, Guerrero-Castillo JI, Martínez-Benítez B, Sifuentes-Osornio J. Gac Med Mex. 2019;155(3):266-275.
  • Analysis of loss to follow-up in 4099 multidrug-resistant pulmonary tuberculosis patients. Walker IF, Shi O, Hicks JP, Elsey H, Wei X, Menzies D, Lan Z, Falzon D, Migliori GB, Pérez-Guzmán C, Vargas MH, García-García L, Sifuentes Osornio J, Ponce-De-León A, van der Walt M, Newell JN. Eur Respir J. 2019 Jul 11;54(1).
  • Consensus on the prevention, diagnosis, and treatment of Clostridium difficile infection. Abreu Y Abreu AT, Velarde-Ruiz Velasco JA, Zavala-Solares MR, Remes-Troche JM, Carmona-Sánchez RI, Aldana-Ledesma JM, Camacho-Ortiz A, Contreras-Omaña R, Díaz-Seoane R, Elizondo-Vázquez CT, Garza-González E, Grajales-Figueroa G, Gómez-Escudero O, Jacobo-Karam JS, Morales-Arámbula M, Olivares-Guzmán LO, Sifuentes-Osornio J, Siu-Moguel AG, Soto-Solís R, Valdovinos-García LR, Valdovinos-Díaz MA, Vázquez-Elizondo G, Lazo-de la Vega Jasso SA. Rev Gastroenterol Mex. 2019 Apr – Jun;84(2):204-219.
  • Potential Effect of Statins on Mycobacterium tuberculosis Infection. Guerra-De-Blas PDC, Torres-González P, Bobadilla-Del-Valle M, Sada-Ovalle I, Ponce-De-León-Garduño A, Sifuentes-Osornio J. J Immunol Res. 2018 Nov 15;2018:7617023.
  • Risk factors associated with prolonged hospital length-of-stay: 18-year retrospective study of hospitalizations in a tertiary healthcare center in Mexico. Marfil-Garza BA, Belaunzarán-Zamudio PF, Gulias-Herrero A, Zuñiga AC, Caro-Vega Y, Kershenobich-Stalnikowitz D, Sifuentes-Osornio J. PLoS One. 2018 Nov 8;13(11):e0207203.
  • Diagnostic accuracy cohort study and clinical value of the Histoplasma urine antigen (ALPHA Histoplasma EIA) for disseminated histoplasmosis among HIV infected patients: A multicenter study. Torres-González P, Niembro-Ortega MD, Martínez-Gamboa A, Ahumada-Topete VH, Andrade-Villanueva J, Araujo-Meléndez J, Chaparro-Sánchez A, Crabtree-Ramírez B, Cruz-Martínez S, Gamboa-Domínguez A, Flores-Barrientos OI, Gaytán-Martínez JE, González-Hernández LA, Hernández-León C, Lozano-Fernandez VH, Manríquez-Reyes M, Magaña-Aquino M, Martínez-Ayala P, Ramírez-Hinojosa JP, Rangel-Cordero A, Rivera-Martínez NE, Reyes-Gutiérrez E, Reyes-Terán G, Rodríguez-Zulueta P, Ruíz-Quiñones J, Santiago-Cruz J, Velázquez-Zavala NG, Sifuentes-Osornio J, Ponce de León A. PLoS Negl Trop Dis. 2018 Nov 5;12(11):e0006872.
  • Mycobacterium tuberculosis complex bacteremia among HIV and non-HIV patients in a Mexican tertiary care center. Tamez-Torres KM, Torres-Gonzalez P, Cervera-Hernandez ME, Chavez-Mazari B, Barrientos-Flores CJ, Bobadilla-Del-Valle M, Ponce-de-Leon A, Sifuentes-Osornio J. Braz J Infect Dis. 2018 Sep – Oct;22(5):387-391.
  • Pneumonia in patients with systemic lupus erythematosus: Epidemiology, microbiology and outcomes. García-Guevara G, Ríos-Corzo R, Díaz-Mora A, López-López M, Hernández-Flores J, Fragoso-Loyo H, Ávila-Vázquez J, Pulido-Ramírez AL, Carrillo-Maravilla E, Jakez-Ocampo J, Sifuentes-Osornio J, Llorente L, Atisha-Fregoso Y. Lupus. 2018 Oct;27(12):1953-1959.